APO Research
Talk to an analyst

APO RESEARCH · REPORT

Anemia Drugs

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Anemia Drugs Industry Growth and Trends Forecast to 2032

20 December 2025100 pages

Choose your research edition.

Industry ResearchAnemia Drugs Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal Anemia Drugs Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Anemia Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Anemia Drugs Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Anemia Drugs Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Anemia Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Anemia Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Anemia Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Anemia Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Anemia Drugs include Eli Lilly, GlaxoSmithKline, Bayer AG, Regen Biopharma, Pieris Pharmaceuticals, Onconova Therapeutics, Mast Therapeutics, GlycoMimetics and Global Blood Therapeutics (GBT), among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Anemia Drugs market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Anemia Drugs market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Anemia Drugs market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Anemia Drugs.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Anemia Drugs market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Anemia Drugs Market by Company

Eli Lilly

GlaxoSmithKline

Bayer AG

Regen Biopharma

Pieris Pharmaceuticals

Onconova Therapeutics

Mast Therapeutics

GlycoMimetics

Global Blood Therapeutics (GBT)

Fibrogen

Celgene Corporation

Bluebird Bio

Akebia Therapeutics

Acceleron Pharma

Anemia Drugs Segment by Type

Oral

Injection

Anemia Drugs Segment by Application

Aplastic Anemia

Iron Deficiency Anemia

Chronic Kidney Disease related Anemia

Sickle Cell Anemia

Anemia Drugs Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Anemia Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Anemia Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Anemia Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Anemia Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Anemia Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Oral Table 2. Major Company of Injection Table 3. Global Anemia Drugs Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Anemia Drugs Sales by Type (2021-2026) & (K Units) Table 5. Global Anemia Drugs Sales Market Share in Volume by Type (2021-2026) Table 6. Global Anemia Drugs Sales by Type (2021-2026) & (US$ Million) Table 7. Global Anemia Drugs Sales Market Share in Value by Type (2021-2026) Table 8. Global Anemia Drugs Price by Type (2021-2026) & (US$/Unit) Table 9. Global Anemia Drugs Sales by Type (2027-2032) & (K Units) Table 10. Global Anemia Drugs Sales Market Share in Volume by Type (2027-2032) Table 11. Global Anemia Drugs Sales by Type (2027-2032) & (US$ Million) Table 12. Global Anemia Drugs Sales Market Share in Value by Type (2027-2032) Table 13. Global Anemia Drugs Price by Type (2027-2032) & (US$/Unit) Table 14. North America Anemia Drugs Sales by Type (2021-2026) & (K Units) Table 15. North America Anemia Drugs Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Anemia Drugs Sales by Type (2021-2026) & (K Units) Table 17. Europe Anemia Drugs Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Anemia Drugs Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Anemia Drugs Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Anemia Drugs Sales by Type (2021-2026) & (K Units) Table 21. Latin America Anemia Drugs Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Anemia Drugs Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Anemia Drugs Sales by Type (2021-2026) & (US$ Million) Table 24. Anemia Drugs Industry Trends Table 25. Anemia Drugs Industry Drivers Table 26. Anemia Drugs Industry Opportunities and Challenges Table 27. Anemia Drugs Industry Restraints Table 28. Global Anemia Drugs Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Anemia Drugs Revenue Market Share by Company (2021-2026) Table 30. Global Anemia Drugs Sales by Company (2021-2026) & (K Units) Table 31. Global Anemia Drugs Sales Share by Company (2021-2026) Table 32. Global Anemia Drugs Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Anemia Drugs Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Anemia Drugs Major Company Production Sites and Headquarters Table 35. Global Anemia Drugs Company, Product Type & Application Table 36. Global Anemia Drugs Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Anemia Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Anemia Drugs Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Anemia Drugs Sales by Region (2021-2026) & (K Units) Table 41. Global Anemia Drugs Sales Market Share in Volume by Region (2021-2026) Table 42. Global Anemia Drugs Sales by Region (2021-2026) & (US$ Million) Table 43. Global Anemia Drugs Sales Market Share in Value by Region (2021-2026) Table 44. Global Anemia Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Anemia Drugs Sales by Region (2027-2032) & (K Units) Table 46. Global Anemia Drugs Sales Market Share in Volume by Region (2027-2032) Table 47. Global Anemia Drugs Sales by Region (2027-2032) & (US$ Million) Table 48. Global Anemia Drugs Sales Market Share in Value by Region (2027-2032) Table 49. Global Anemia Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Anemia Drugs Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Anemia Drugs Sales by Application (2021-2026) & (K Units) Table 52. Global Anemia Drugs Sales Market Share in Volume by Application (2021-2026) Table 53. Global Anemia Drugs Sales by Application (2021-2026) & (US$ Million) Table 54. Global Anemia Drugs Sales Market Share in Value by Application (2021-2026) Table 55. Global Anemia Drugs Price by Application (2021-2026) & (US$/Unit) Table 56. Global Anemia Drugs Sales by Application (2027-2032) & (K Units) Table 57. Global Anemia Drugs Sales Market Share in Volume by Application (2027-2032) Table 58. Global Anemia Drugs Sales by Application (2027-2032) & (US$ Million) Table 59. Global Anemia Drugs Sales Market Share in Value by Application (2027-2032) Table 60. Global Anemia Drugs Price by Application (2027-2032) & (US$/Unit) Table 61. North America Anemia Drugs Sales by Application (2021-2026) & (K Units) Table 62. North America Anemia Drugs Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Anemia Drugs Sales by Application (2021-2026) & (K Units) Table 64. Europe Anemia Drugs Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Anemia Drugs Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Anemia Drugs Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Anemia Drugs Sales by Application (2021-2026) & (K Units) Table 68. Latin America Anemia Drugs Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Anemia Drugs Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Anemia Drugs Sales by Application (2021-2026) & (US$ Million) Table 71. Eli Lilly Company Information Table 72. Eli Lilly Business Overview Table 73. Eli Lilly Anemia Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Eli Lilly Anemia Drugs Product Portfolio Table 75. Eli Lilly Recent Development Table 76. GlaxoSmithKline Company Information Table 77. GlaxoSmithKline Business Overview Table 78. GlaxoSmithKline Anemia Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. GlaxoSmithKline Anemia Drugs Product Portfolio Table 80. GlaxoSmithKline Recent Development Table 81. Bayer AG Company Information Table 82. Bayer AG Business Overview Table 83. Bayer AG Anemia Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Bayer AG Anemia Drugs Product Portfolio Table 85. Bayer AG Recent Development Table 86. Regen Biopharma Company Information Table 87. Regen Biopharma Business Overview Table 88. Regen Biopharma Anemia Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Regen Biopharma Anemia Drugs Product Portfolio Table 90. Regen Biopharma Recent Development Table 91. Pieris Pharmaceuticals Company Information Table 92. Pieris Pharmaceuticals Business Overview Table 93. Pieris Pharmaceuticals Anemia Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Pieris Pharmaceuticals Anemia Drugs Product Portfolio Table 95. Pieris Pharmaceuticals Recent Development Table 96. Onconova Therapeutics Company Information Table 97. Onconova Therapeutics Business Overview Table 98. Onconova Therapeutics Anemia Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Onconova Therapeutics Anemia Drugs Product Portfolio Table 100. Onconova Therapeutics Recent Development Table 101. Mast Therapeutics Company Information Table 102. Mast Therapeutics Business Overview Table 103. Mast Therapeutics Anemia Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Mast Therapeutics Anemia Drugs Product Portfolio Table 105. Mast Therapeutics Recent Development Table 106. GlycoMimetics Company Information Table 107. GlycoMimetics Business Overview Table 108. GlycoMimetics Anemia Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. GlycoMimetics Anemia Drugs Product Portfolio Table 110. GlycoMimetics Recent Development Table 111. Global Blood Therapeutics (GBT) Company Information Table 112. Global Blood Therapeutics (GBT) Business Overview Table 113. Global Blood Therapeutics (GBT) Anemia Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Global Blood Therapeutics (GBT) Anemia Drugs Product Portfolio Table 115. Global Blood Therapeutics (GBT) Recent Development Table 116. Fibrogen Company Information Table 117. Fibrogen Business Overview Table 118. Fibrogen Anemia Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. Fibrogen Anemia Drugs Product Portfolio Table 120. Fibrogen Recent Development Table 121. Celgene Corporation Company Information Table 122. Celgene Corporation Business Overview Table 123. Celgene Corporation Anemia Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 124. Celgene Corporation Anemia Drugs Product Portfolio Table 125. Celgene Corporation Recent Development Table 126. Bluebird Bio Company Information Table 127. Bluebird Bio Business Overview Table 128. Bluebird Bio Anemia Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 129. Bluebird Bio Anemia Drugs Product Portfolio Table 130. Bluebird Bio Recent Development Table 131. Akebia Therapeutics Company Information Table 132. Akebia Therapeutics Business Overview Table 133. Akebia Therapeutics Anemia Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 134. Akebia Therapeutics Anemia Drugs Product Portfolio Table 135. Akebia Therapeutics Recent Development Table 136. Acceleron Pharma Company Information Table 137. Acceleron Pharma Business Overview Table 138. Acceleron Pharma Anemia Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 139. Acceleron Pharma Anemia Drugs Product Portfolio Table 140. Acceleron Pharma Recent Development Table 141. North America Anemia Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 142. North America Anemia Drugs Sales by Country (2021-2026) & (K Units) Table 143. North America Anemia Drugs Sales Market Share by Country (2021-2026) Table 144. North America Anemia Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 145. North America Anemia Drugs Sales Market Share Forecast by Country (2027-2032) Table 146. North America Anemia Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. North America Anemia Drugs Market Size by Country (2021-2026) & (US$ Million) Table 148. North America Anemia Drugs Market Share by Country (2021-2026) Table 149. North America Anemia Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. North America Anemia Drugs Market Share Forecast by Country (2027-2032) Table 151. Europe Anemia Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 152. Europe Anemia Drugs Sales by Country (2021-2026) & (K Units) Table 153. Europe Anemia Drugs Sales Market Share by Country (2021-2026) Table 154. Europe Anemia Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 155. Europe Anemia Drugs Sales Market Share Forecast by Country (2027-2032) Table 156. Europe Anemia Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 157. Europe Anemia Drugs Market Size by Country (2021-2026) & (US$ Million) Table 158. Europe Anemia Drugs Market Share by Country (2021-2026) Table 159. Europe Anemia Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 160. Europe Anemia Drugs Market Share Forecast by Country (2027-2032) Table 161. Asia-Pacific Anemia Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 162. Asia-Pacific Anemia Drugs Sales by Country (2021-2026) & (K Units) Table 163. Asia-Pacific Anemia Drugs Sales Market Share by Country (2021-2026) Table 164. Asia-Pacific Anemia Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 165. Asia-Pacific Anemia Drugs Sales Market Share Forecast by Country (2027-2032) Table 166. Asia-Pacific Anemia Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 167. Asia-Pacific Anemia Drugs Market Size by Country (2021-2026) & (US$ Million) Table 168. Asia-Pacific Anemia Drugs Market Share by Country (2021-2026) Table 169. Asia-Pacific Anemia Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 170. Asia-Pacific Anemia Drugs Market Share Forecast by Country (2027-2032) Table 171. Latin America Anemia Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 172. Latin America Anemia Drugs Sales by Country (2021-2026) & (K Units) Table 173. Latin America Anemia Drugs Sales Market Share by Country (2021-2026) Table 174. Latin America Anemia Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 175. Latin America Anemia Drugs Sales Market Share Forecast by Country (2027-2032) Table 176. Latin America Anemia Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 177. Latin America Anemia Drugs Market Size by Country (2021-2026) & (US$ Million) Table 178. Latin America Anemia Drugs Market Share by Country (2021-2026) Table 179. Latin America Anemia Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 180. Latin America Anemia Drugs Market Share Forecast by Country (2027-2032) Table 181. Middle East and Africa Anemia Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 182. Middle East and Africa Anemia Drugs Sales by Country (2021-2026) & (K Units) Table 183. Middle East and Africa Anemia Drugs Sales Market Share by Country (2021-2026) Table 184. Middle East and Africa Anemia Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 185. Middle East and Africa Anemia Drugs Sales Market Share Forecast by Country (2027-2032) Table 186. Middle East and Africa Anemia Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 187. Middle East and Africa Anemia Drugs Market Size by Country (2021-2026) & (US$ Million) Table 188. Middle East and Africa Anemia Drugs Market Share by Country (2021-2026) Table 189. Middle East and Africa Anemia Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 190. Middle East and Africa Anemia Drugs Market Share Forecast by Country (2027-2032) Table 191. Key Raw Materials Table 192. Raw Materials Key Suppliers Table 193. Anemia Drugs Distributors List Table 194. Anemia Drugs Customers List Table 195. Research Programs/Design for This Report Table 196. Authors List of This Report Table 197. Secondary Sources Table 198. Primary Sources List of Figures Figure 1. Anemia Drugs Image Figure 2. Global Anemia Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Anemia Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Anemia Drugs Sales (2021-2032) & (K Units) Figure 5. Oral Image Figure 6. Global Oral Sales YoY Growth (2021-2032) & (K Units) Figure 7. Injection Image Figure 8. Global Injection Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Anemia Drugs Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Anemia Drugs Market Share by Type 2025 VS 2032 Figure 11. North America Anemia Drugs Sales Market Share in Volume by Type in 2025 Figure 12. North America Anemia Drugs Sales Market Share in Value by Type in 2025 Figure 13. Europe Anemia Drugs Sales Market Share in Volume by Type in 2025 Figure 14. Europe Anemia Drugs Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Anemia Drugs Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Anemia Drugs Sales Market Share in Value by Type in 2025 Figure 17. Latin America Anemia Drugs Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Anemia Drugs Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Anemia Drugs Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Anemia Drugs Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Anemia Drugs Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Aplastic Anemia Image Figure 24. Global Aplastic Anemia Sales YoY Growth (2021-2032) & (K Units) Figure 25. Iron Deficiency Anemia Image Figure 26. Global Iron Deficiency Anemia Sales YoY Growth (2021-2032) & (K Units) Figure 27. Chronic Kidney Disease related Anemia Image Figure 28. Global Chronic Kidney Disease related Anemia Sales YoY Growth (2021-2032) & (K Units) Figure 29. Sickle Cell Anemia Image Figure 30. Global Sickle Cell Anemia Sales YoY Growth (2021-2032) & (K Units) Figure 31. Global Anemia Drugs Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Anemia Drugs Market Share by Application 2025 VS 2032 Figure 33. North America Anemia Drugs Sales Market Share in Volume by Application in 2025 Figure 34. North America Anemia Drugs Sales Market Share in Value by Application in 2025 Figure 35. Europe Anemia Drugs Sales Market Share in Volume by Application in 2025 Figure 36. Europe Anemia Drugs Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Anemia Drugs Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Anemia Drugs Sales Market Share in Value by Application in 2025 Figure 39. Latin America Anemia Drugs Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Anemia Drugs Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Anemia Drugs Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Anemia Drugs Sales Market Share in Value by Application in 2025 Figure 43. North America Anemia Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 44. North America Anemia Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Anemia Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Anemia Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Anemia Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. Europe Anemia Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Anemia Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Anemia Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Anemia Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Asia-Pacific Anemia Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Anemia Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Anemia Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Anemia Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Latin America Anemia Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Anemia Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Anemia Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Anemia Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Middle East and Africa Anemia Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Anemia Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Anemia Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Anemia Drugs Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Anemia Drugs Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Oral
  • Injection
Applications
  • Aplastic Anemia
  • Iron Deficiency Anemia
  • Chronic Kidney Disease related Anemia
  • Sickle Cell Anemia
Companies covered
  • Eli Lilly
  • GlaxoSmithKline
  • Bayer AG
  • Regen Biopharma
  • Pieris Pharmaceuticals
  • Onconova Therapeutics
  • Mast Therapeutics
  • GlycoMimetics
  • Global Blood Therapeutics (GBT)
  • Fibrogen
  • Celgene Corporation
  • Bluebird Bio
  • Akebia Therapeutics
  • Acceleron Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Anemia Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Anemia Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Anemia Drugs Market by Type
  6. 1.3.1 Oral
  7. 1.3.2 Injection
  8. 1.4 Global Anemia Drugs Market Size by Type
  9. 1.4.1 Global Anemia Drugs Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Anemia Drugs Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Anemia Drugs Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Anemia Drugs Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Anemia Drugs Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Anemia Drugs Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Anemia Drugs Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Anemia Drugs Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Anemia Drugs Industry Trends
  2. 2.2 Anemia Drugs Industry Drivers
  3. 2.3 Anemia Drugs Industry Opportunities and Challenges
  4. 2.4 Anemia Drugs Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Anemia Drugs Revenue (2021-2026)
  2. 3.2 Global Top Players by Anemia Drugs Sales (2021-2026)
  3. 3.3 Global Top Players by Anemia Drugs Price (2021-2026)
  4. 3.4 Global Anemia Drugs Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Anemia Drugs Major Company Production Sites & Headquarters
  6. 3.6 Global Anemia Drugs Company, Product Type & Application
  7. 3.7 Global Anemia Drugs Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Anemia Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Anemia Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Anemia Drugs Tier 1, Tier 2, and Tier 3
4 Anemia Drugs Regional Status and Outlook
  1. 4.1 Global Anemia Drugs Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Anemia Drugs Historic Market Size by Region
  3. 4.2.1 Global Anemia Drugs Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Anemia Drugs Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Anemia Drugs Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Anemia Drugs Forecasted Market Size by Region
  7. 4.3.1 Global Anemia Drugs Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Anemia Drugs Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Anemia Drugs Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Anemia Drugs by Application
  1. 5.1 Anemia Drugs Market by Application
  2. 5.1.1 Aplastic Anemia
  3. 5.1.2 Iron Deficiency Anemia
  4. 5.1.3 Chronic Kidney Disease related Anemia
  5. 5.1.4 Sickle Cell Anemia
  6. 5.2 Global Anemia Drugs Market Size by Application
  7. 5.2.1 Global Anemia Drugs Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Anemia Drugs Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Anemia Drugs Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Anemia Drugs Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Anemia Drugs Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Anemia Drugs Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Anemia Drugs Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Anemia Drugs Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Eli Lilly
  2. 6.1.1 Eli Lilly Company Information
  3. 6.1.2 Eli Lilly Business Overview
  4. 6.1.3 Eli Lilly Anemia Drugs Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Eli Lilly Anemia Drugs Product Portfolio
  6. 6.1.5 Eli Lilly Recent Developments
  7. 6.2 GlaxoSmithKline
  8. 6.2.1 GlaxoSmithKline Company Information
  9. 6.2.2 GlaxoSmithKline Business Overview
  10. 6.2.3 GlaxoSmithKline Anemia Drugs Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 GlaxoSmithKline Anemia Drugs Product Portfolio
  12. 6.2.5 GlaxoSmithKline Recent Developments
  13. 6.3 Bayer AG
  14. 6.3.1 Bayer AG Company Information
  15. 6.3.2 Bayer AG Business Overview
  16. 6.3.3 Bayer AG Anemia Drugs Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Bayer AG Anemia Drugs Product Portfolio
  18. 6.3.5 Bayer AG Recent Developments
  19. 6.4 Regen Biopharma
  20. 6.4.1 Regen Biopharma Company Information
  21. 6.4.2 Regen Biopharma Business Overview
  22. 6.4.3 Regen Biopharma Anemia Drugs Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Regen Biopharma Anemia Drugs Product Portfolio
  24. 6.4.5 Regen Biopharma Recent Developments
  25. 6.5 Pieris Pharmaceuticals
  26. 6.5.1 Pieris Pharmaceuticals Company Information
  27. 6.5.2 Pieris Pharmaceuticals Business Overview
  28. 6.5.3 Pieris Pharmaceuticals Anemia Drugs Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Pieris Pharmaceuticals Anemia Drugs Product Portfolio
  30. 6.5.5 Pieris Pharmaceuticals Recent Developments
  31. 6.6 Onconova Therapeutics
  32. 6.6.1 Onconova Therapeutics Company Information
  33. 6.6.2 Onconova Therapeutics Business Overview
  34. 6.6.3 Onconova Therapeutics Anemia Drugs Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Onconova Therapeutics Anemia Drugs Product Portfolio
  36. 6.6.5 Onconova Therapeutics Recent Developments
  37. 6.7 Mast Therapeutics
  38. 6.7.1 Mast Therapeutics Company Information
  39. 6.7.2 Mast Therapeutics Business Overview
  40. 6.7.3 Mast Therapeutics Anemia Drugs Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Mast Therapeutics Anemia Drugs Product Portfolio
  42. 6.7.5 Mast Therapeutics Recent Developments
  43. 6.8 GlycoMimetics
  44. 6.8.1 GlycoMimetics Company Information
  45. 6.8.2 GlycoMimetics Business Overview
  46. 6.8.3 GlycoMimetics Anemia Drugs Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 GlycoMimetics Anemia Drugs Product Portfolio
  48. 6.8.5 GlycoMimetics Recent Developments
  49. 6.9 Global Blood Therapeutics (GBT)
  50. 6.9.1 Global Blood Therapeutics (GBT) Company Information
  51. 6.9.2 Global Blood Therapeutics (GBT) Business Overview
  52. 6.9.3 Global Blood Therapeutics (GBT) Anemia Drugs Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Global Blood Therapeutics (GBT) Anemia Drugs Product Portfolio
  54. 6.9.5 Global Blood Therapeutics (GBT) Recent Developments
  55. 6.10 Fibrogen
  56. 6.10.1 Fibrogen Company Information
  57. 6.10.2 Fibrogen Business Overview
  58. 6.10.3 Fibrogen Anemia Drugs Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Fibrogen Anemia Drugs Product Portfolio
  60. 6.10.5 Fibrogen Recent Developments
  61. 6.11 Celgene Corporation
  62. 6.11.1 Celgene Corporation Company Information
  63. 6.11.2 Celgene Corporation Business Overview
  64. 6.11.3 Celgene Corporation Anemia Drugs Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Celgene Corporation Anemia Drugs Product Portfolio
  66. 6.11.5 Celgene Corporation Recent Developments
  67. 6.12 Bluebird Bio
  68. 6.12.1 Bluebird Bio Company Information
  69. 6.12.2 Bluebird Bio Business Overview
  70. 6.12.3 Bluebird Bio Anemia Drugs Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Bluebird Bio Anemia Drugs Product Portfolio
  72. 6.12.5 Bluebird Bio Recent Developments
  73. 6.13 Akebia Therapeutics
  74. 6.13.1 Akebia Therapeutics Company Information
  75. 6.13.2 Akebia Therapeutics Business Overview
  76. 6.13.3 Akebia Therapeutics Anemia Drugs Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Akebia Therapeutics Anemia Drugs Product Portfolio
  78. 6.13.5 Akebia Therapeutics Recent Developments
  79. 6.14 Acceleron Pharma
  80. 6.14.1 Acceleron Pharma Company Information
  81. 6.14.2 Acceleron Pharma Business Overview
  82. 6.14.3 Acceleron Pharma Anemia Drugs Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Acceleron Pharma Anemia Drugs Product Portfolio
  84. 6.14.5 Acceleron Pharma Recent Developments
7 North America by Country
  1. 7.1 North America Anemia Drugs Sales by Country
  2. 7.1.1 North America Anemia Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Anemia Drugs Sales by Country (2021-2026)
  4. 7.1.3 North America Anemia Drugs Sales Forecast by Country (2027-2032)
  5. 7.2 North America Anemia Drugs Market Size by Country
  6. 7.2.1 North America Anemia Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Anemia Drugs Market Size by Country (2021-2026)
  8. 7.2.3 North America Anemia Drugs Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Anemia Drugs Sales by Country
  2. 8.1.1 Europe Anemia Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Anemia Drugs Sales by Country (2021-2026)
  4. 8.1.3 Europe Anemia Drugs Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Anemia Drugs Market Size by Country
  6. 8.2.1 Europe Anemia Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Anemia Drugs Market Size by Country (2021-2026)
  8. 8.2.3 Europe Anemia Drugs Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Anemia Drugs Sales by Country
  2. 9.1.1 Asia-Pacific Anemia Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Anemia Drugs Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Anemia Drugs Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Anemia Drugs Market Size by Country
  6. 9.2.1 Asia-Pacific Anemia Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Anemia Drugs Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Anemia Drugs Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Anemia Drugs Sales by Country
  2. 10.1.1 South America Anemia Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Anemia Drugs Sales by Country (2021-2026)
  4. 10.1.3 South America Anemia Drugs Sales Forecast by Country (2027-2032)
  5. 10.2 South America Anemia Drugs Market Size by Country
  6. 10.2.1 South America Anemia Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Anemia Drugs Market Size by Country (2021-2026)
  8. 10.2.3 South America Anemia Drugs Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Anemia Drugs Sales by Country
  2. 11.1.1 Middle East and Africa Anemia Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Anemia Drugs Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Anemia Drugs Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Anemia Drugs Market Size by Country
  6. 11.2.1 Middle East and Africa Anemia Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Anemia Drugs Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Anemia Drugs Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Anemia Drugs Value Chain Analysis
  2. 12.1.1 Anemia Drugs Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Anemia Drugs Production Mode & Process
  7. 12.2 Anemia Drugs Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Anemia Drugs Distributors
  10. 12.2.3 Anemia Drugs Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst